-TheWire Science * The Indian government has consistently discouraged Compulsory licenses on generic drugs.   * One of the big questions the India government has not answered is why it isn’t using pharma PSUs to produce drugs and vaccines. * Not one member of Indian industry is willing to stand up and fight for Compulsory licenses, and for patients, says lawyer Murali Neelakantan. India has played a crucial role in supporting South Africa, as a...

Scientific knowledge has immensely helped in combating the dreadful coronavirus and its spread. Within a record short period of time, scientists (including virologists, epidemiologists, biostatisticians, etc.) and their research outputs helped the commoners to learn more about the SARS-CoV-2 and how it spreads from one individual to the next one. Common people have now come to know how simple techniques and behavioural change like the wearing of N95 masks, maintaining...

-The Hindu Business Line WTO has allowed countries to issue Compulsory licenses during emergencies A Division Bench of the Kerala High Court on Tuesday asked the Centre to respond to a plea for invoking the compulsory licensing to allow other capable vaccine manufacturers to produce Covid vaccines. The Bench comprising Justice Raja Vijayaraghavan and Justice M.R.Anitha passed the directive when a public interest litigation in this regard came up for hearing. The petition...

-CaravanMagazine.in The economist Jean Drèze’s book, Sense and Solidarity, published in late 2017, deals with the impact of Aadhaar on social-welfare programmes, such as the National Food Security Act and the Mahatma Gandhi National Rural Employment Guarantee Scheme, among other things. Drèze was a member of the United Progressive Alliance government’s advisory council, which designed the NFSA and MGNREGS. He co-authored some of the essays in this book with colleagues and...

-The Hindu While Monsanto and Indian seed companies spar, more worrying is the confused lawmaking underpinning regulation of patents Genetically Modified Organisms (GMOs) breed controversy like no other. Little wonder then that Monsanto’s much-maligned Bt cotton has spawned the mother of all intellectual property (IP) disputes in India, involving at least 15 different proceedings in various courts, government agencies and tribunals at last count. Most proceedings appear to have come at the behest...